Susquehanna International Group
RCEL icon

Susquehanna International Group’s Avita Medical RCEL Stock Holding History

Susquehanna International Group’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-35,193
Closed -$180K – 13385
2025
Q3 		$180K Buy
35,193
+617
+2% +$3.22K ﹤0.01% 11102
2025
Q2 		$183K Sell
34,576
-4,630
-12% -$33.7K ﹤0.01% 11301
2025
Q1 		$319K Buy
39,206
+23,742
+154% +$222K ﹤0.01% 9930
2024
Q4 		$198K Buy
+15,464
New +$182K ﹤0.01% 10737
2024
Q3 		– Sell
-11,627
Closed -$109K – 12847
2024
Q2 		$92.1K Sell
11,627
-9,042
-44% -$86K ﹤0.01% 11081
2024
Q1 		$331K Sell
20,669
-23,416
-53% -$379K ﹤0.01% 9486
2023
Q4 		$605K Sell
44,085
-12,504
-22% -$143K ﹤0.01% 8192
2023
Q3 		$827K Sell
56,589
-23,223
-29% -$393K ﹤0.01% 7073
2023
Q2 		$1.36M Sell
79,812
-150,265
-65% -$2.2M ﹤0.01% 5984
2023
Q1 		$3.21M Buy
230,077
+154,468
+204% +$1.64M ﹤0.01% 4191
2022
Q4 		$499K Buy
+75,609
New +$453K ﹤0.01% 7879
2022
Q3 		– Sell
-74,526
Closed -$460K – 13954
2022
Q2 		$354K Buy
74,526
+25,232
+51% +$156K ﹤0.01% 9114
2022
Q1 		$418K Buy
49,294
+34,270
+228% +$316K ﹤0.01% 9429
2021
Q4 		$180K Sell
15,024
-13,110
-47% -$200K ﹤0.01% 11574
2021
Q3 		$499K Buy
28,134
+9,316
+50% +$176K ﹤0.01% 9412
2021
Q2 		$386K Sell
18,818
-101,403
-84% -$2M ﹤0.01% 10215
2021
Q1 		$2.38M Buy
120,221
+96,555
+408% +$2.25M ﹤0.01% 5490
2020
Q4 		$440K Buy
23,666
+12,259
+107% +$269K ﹤0.01% 8556
2020
Q3 		$287K Buy
11,407
+3,971
+53% +$99K ﹤0.01% 8798
2020
Q2 		$227K Buy
+7,436
New +$227K ﹤0.01% 8817

Other funds holding RCEL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group's RCEL Position: Q4 2025 in Review

Susquehanna International Group sold out of Avita Medical (RCEL) in Q4 2025, closing a stake of 35,193 shares — an estimated $180K sold.

Susquehanna International Group first reported a position in RCEL in Q2 2020 and held it in 20 quarters. The position peaked at $3.21M in Q1 2023. 67 funds tracked by Wall St. Rank hold RCEL as of Q4 2025.

  • Susquehanna International Group reported no remaining Avita Medical position as of Q4 2025 after selling out during the quarter.
  • Susquehanna International Group sold 35,193 Avita Medical shares in Q4 2025, an estimated $180K.
  • Susquehanna International Group first reported a position in Avita Medical in Q2 2020 and held it in 20 quarters.
  • Susquehanna International Group's Avita Medical position peaked at $3.21M in Q1 2023.
  • 67 funds tracked by Wall St. Rank held Avita Medical as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.